📰 Sprint Bioscience News
Sprint Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sprint Bioscience. Real-time updates on events, politics, business and more.
May 6, 2024
A collaborative team effort led by the Tumor Immunotherapy and Microenvironment (TIME) group at the Luxembourg Institute of Health, along with Sprint Bioscience and Karolinska Institutet (Sweden) has discovered a promising new approach for cancer treatment. Click to read more...
August 17, 2023
Day One Biopharmaceuticals has signed a license agreement and research partnership with Sprint Bioscience to advance VRK1 programme.
August 16, 2023
Day One receives an exclusive license to develop and commercialize small molecule drug candidates for pediatric and adult cancers with high unmet need Collaboration augments Day One’s portfolio... -Today at 08:02 am- MarketScreener
October 31, 2022
With effect from November 01, 2022, the unit rights in Sprint Bioscience AB will be traded on First North Premier Growth Market. Trading will continue up until and including November 10, 2022. Instrument:
October 15, 2021
/PRNewswire/ -- Immunovia AB (publ) ("Immunovia"), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer,...
October 15, 2021
LUND, Sweden, Oct. 15, 2021 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia"), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer, announced